Chris F Johnson
Patient factors associated with SSRI dose for depression treatment in general practice: A primary care cross sectional study
Johnson, Chris F; Dougall, Nadine J; Williams, Brian; MacGillivray, Stephen A; Buchanan, Alasdair I; Hassett, Richard D
Authors
Prof Nadine Dougall N.Dougall@napier.ac.uk
Professor
Brian Williams
Stephen A MacGillivray
Alasdair I Buchanan
Richard D Hassett
Abstract
Background
Antidepressant prescribing continues to rise. Increased long-term prescribing and higher doses are contributing to current growth; however, patient factors associated with the use of higher doses remain unknown. This study’s aim was to investigate patient factors associated with selective serotonin re-uptake inhibitor (SSRI) prescribed daily dose for depression treatment in general practice.
Methods
A stratified sample of low to high prescribing practices were selected. Routine individual patient-level data were extracted one practice at a time: September 2009 to January 2011. Patients included were ≥18 years, and prescribed an SSRI for depression. Logistic regression analysis was undertaken to assess individual predictor variables on SSRI daily dose by standard therapeutic dose versus higher dose, as SSRIs demonstrate flat dose response curves for depression treatment. Predictor variables included: age, gender, deprivation, co-morbidity, smoking status, being prescribed the same SSRI for ≥2 years, and patients’ general practice. For a subgroup of patients a second sub-group analysis included long-term benzodiazepine and/or z-hypnotic (B&Z) as a predictor variable.
Results
Inter-practice SSRI prescribing varied significantly; practice point prevalence ranged from 2.5% (94/3697) to 11.9% (359/3007) of the practice population ≥18 years old; median 7.3% (250/3421) (χ2 = 2277.2, df = 10, p
Citation
Johnson, C. F., Dougall, N. J., Williams, B., MacGillivray, S. A., Buchanan, A. I., & Hassett, R. D. (2014). Patient factors associated with SSRI dose for depression treatment in general practice: A primary care cross sectional study. BMC Family Practice, 15(210), https://doi.org/10.1186/s12875-014-0210-9
Journal Article Type | Article |
---|---|
Acceptance Date | Dec 12, 2014 |
Online Publication Date | Dec 24, 2014 |
Publication Date | 2014-12 |
Deposit Date | Mar 1, 2018 |
Publicly Available Date | Mar 5, 2018 |
Journal | BMC Family Practice |
Print ISSN | 1471-2296 |
Publisher | BMC |
Peer Reviewed | Peer Reviewed |
Volume | 15 |
Issue | 210 |
DOI | https://doi.org/10.1186/s12875-014-0210-9 |
Keywords | Family practice, chronic disease, depression, antidepressive agents, Benzodiazepines |
Public URL | http://researchrepository.napier.ac.uk/Output/837685 |
Contract Date | Mar 5, 2018 |
Files
Patient factors associated with SSRI dose for depression treatment...
(367 Kb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
Copyright Statement
© 2014 Johnson et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
You might also like
The epidemiology of hospital treated traumatic brain injury in Scotland.
(2014)
Journal Article
Downloadable Citations
About Edinburgh Napier Research Repository
Administrator e-mail: repository@napier.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search